Spectrum Pharmaceuticals Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Spectrum Pharmaceuticals Inc.
As the prolonged COVID-19 pandemic continues to take a toll globally, South Korean pharma firms’ overseas drug development activities are increasingly being disrupted by the impact.
Private Company Edition: The flood of venture capital into health care and life science firms continues with Perceptive closing a $1.1bn credit fund and Sanofi investing $50m in Jeito Capital. Also, Ambrx closed a $200m crossover round as biopharma remains on track for a record funding year.
Japanese firm creates new US-based global organization that reaffirms strategic focus on oncology as main pillar of mid-term growth.
Highlights from complete response letter news from the Pink Sheet’s US FDA Performance Tracker.
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Allos Therapeutics, Inc.
- Talon Therapeutics, Inc. (Hana Biosciences, Inc.)